Kidney Transplant Biopsies for Delayed Graft Function. Does it add Therapeutic Value?

Vishwanath Siddagangaiah, Stavros Papachristos, Marcus Lowe, John Blaikley, David Van Dellen, Muir Morton, Titus Augustine

Research output: Contribution to conferencePoster

Abstract

Graft biopsies are performed in kidney transplants with delayed graft function (DGF) to confirm acute tubular necrosis and exclude potential underlying rejection.
•With the increasing use of donor after cardiac death (DCD) and Extended Criteria Donors, DGF incidence is increasing whilst modern immunosuppressive regimes have reduced the incidence of acute rejection to less than 10%.
•Routine biopsies may therefore not provide therapeutic efficiency or financial utility.
•They are known to be associated with potential morbidity.
Original languageEnglish
Publication statusPublished - 10 Mar 2017
EventBritish Transplantation Society Annual Congress: BTS Harrogate - Harrogate, United Kingdom
Duration: 1 Mar 20173 Mar 2017

Conference

ConferenceBritish Transplantation Society Annual Congress
Abbreviated titleBTS 2017
Country/TerritoryUnited Kingdom
CityHarrogate
Period1/03/173/03/17

Fingerprint

Dive into the research topics of 'Kidney Transplant Biopsies for Delayed Graft Function. Does it add Therapeutic Value?'. Together they form a unique fingerprint.

Cite this